TrialCalcified tissue international2013

A novel monthly dosing regimen of risedronate for the treatment of postmenopausal osteoporosis: 2-year data.

Michael R McClung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.